Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
1
Historical Events
0
Regulatory Approvals
QTORIN 3.9% Rapamycin Anhydrous Gel Phase 3 Results Expected
QTORIN 3.9% Rapamycin Anhydrous Gel • Microcystic Lymphatic Malformation
QTORIN 3.9% rapamycin anhydrous gel Phase 2 Results Expected
QTORIN 3.9% Rapamycin Anhydrous Gel • Microcystic Lymphatic Malformation